Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
about
The Pathogenesis of Nonalcoholic Fatty Liver Disease: Interplay between Diet, Gut Microbiota, and Genetic BackgroundNonalcoholic Lipid Accumulation and Hepatocyte Malignant TransformationInsulin resistance in development and progression of nonalcoholic fatty liver diseaseChemoprevention of obesity-related liver carcinogenesis by using pharmaceutical and nutraceutical agentsResearch advances in the relationship between nonalcoholic fatty liver disease and atherosclerosisBile acid receptors and nonalcoholic fatty liver diseaseNonalcoholic Fatty Liver Disease: Dyslipidemia, Risk for Cardiovascular Complications, and Treatment StrategyMetabolic aspects of adult patients with nonalcoholic fatty liver diseaseEffects of exercise training on intrahepatic lipid content in humansTransient elastography (FibroScan(®)) with controlled attenuation parameter in the assessment of liver steatosis and fibrosis in patients with nonalcoholic fatty liver disease - Where do we stand?The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in MiceImpaired lung function is associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in middle-aged and elderly ChineseOmic studies reveal the pathogenic lipid droplet proteins in non-alcoholic fatty liver disease.Metabolic basis of ethnic differences in diabetes risk in overweight and obese youth.Identification of Risk Pathways and Functional Modules for Coronary Artery Disease Based on Genome-wide SNP Data.Licochalcone Suppresses LXRα-Induced Hepatic Lipogenic Gene Expression through AMPK/Sirt1 Pathway Activation.Circulating sCD36 is associated with unhealthy fat distribution and elevated circulating triglycerides in morbidly obese individuals.Relationship between adipose tissue dysfunction, vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease.Genetic factors associated with risk of metabolic syndrome and hepatocellular carcinomaPrevalence of Non Alcoholic Fatty Liver Disease and its Association with Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus.Diet-Induced Low-Grade Metabolic Acidosis and Clinical Outcomes: A Review.Circular RNA Profiling and Bioinformatic Modeling Identify Its Regulatory Role in Hepatic Steatosis.Independent tissue contributors to obesity-associated insulin resistance.Major Components of Metabolic Parameters and Nutritional Intakes in Different Genotypes of Adiponectin +276 G>T Gene Polymorphism in Non-Diabetes and Non-Alcoholic Iranian Fatty Liver Patients.Antihyperglycemic and Anti-Inflammatory Effects of Standardized Curcuma xanthorrhiza Roxb. Extract and Its Active Compound Xanthorrhizol in High-Fat Diet-Induced Obese Mice.Central obesity as a clinical marker of adiposopathy; increased visceral adiposity as a surrogate marker for global fat dysfunctionHigher dietary choline intake is associated with lower risk of nonalcoholic fatty liver in normal-weight Chinese women.Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population.Does vitamin C deficiency promote fatty liver disease development?Fatty acid changes help to better understand regression of nonalcoholic fatty liver diseaseLycopene and apo-10'-lycopenoic acid have differential mechanisms of protection against hepatic steatosis in β-carotene-9',10'-oxygenase knockout male miceA green algae mixture of Scenedesmus and Schroederiella attenuates obesity-linked metabolic syndrome in rats.Fructose Mediated Non-Alcoholic Fatty Liver Is Attenuated by HO-1-SIRT1 Module in Murine Hepatocytes and Mice Fed a High Fructose Diet.Mechanisms Linking Inflammation to Insulin ResistanceNon-Alcoholic Fatty Liver Disease Is a Risk Factor for the Development of Diabetic Nephropathy in Patients with Type 2 Diabetes MellitusPhysical activity as a treatment of non-alcoholic fatty liver disease: A systematic review.Adipocytes as a Link Between Gut Microbiota-Derived Flagellin and Hepatocyte Fat Accumulation.Hypolactasia is associated with insulin resistance in nonalcoholic steatohepatitis.The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis.
P2860
Q26744380-89497ED9-EC3C-4446-A97B-2ECA253CFC9CQ26746521-F3B018AE-D835-497A-9C04-3CEF6C8CD1D1Q26748687-0DD9023C-C0F0-48D1-8F02-35E41E9F121DQ26772302-F0A72CA3-E1F3-452A-9F96-6C023531E0A2Q26775340-9CD056AD-D62B-4228-8531-C35889E49375Q26775814-B3CD2502-C407-4D06-842D-B112FEB19F95Q26781753-8A0828A1-BADC-4157-874E-8362DCF9C174Q28067490-6735250D-12E0-44F8-97EF-F2A15FA6267AQ28071597-2D19E85C-F2EB-444F-AF21-A2A4C3EE5541Q28079445-81AA1B1E-DD42-435C-850B-EADD6555DC24Q28552063-864B8DC0-BD69-46BA-9D13-500871FB7E3DQ29248598-CBBE8198-85D3-4CA2-9166-1B22E0141634Q30244335-51FCEDC7-B419-4A57-B4C1-03FB54DB383AQ30358115-3C1304E2-2873-44A6-98F5-1724257817EFQ31148631-8183873F-CCCE-481B-B3F4-1EEE806CA7BDQ33554328-597D92A3-B693-47E0-8519-5A1EEC3E735CQ33554854-14CF4394-E188-45B8-8759-50FC1CF7A1C8Q33719929-7A4143EE-4A84-466C-BC69-6891ADE61BB6Q33798871-540D7B79-FF3D-4E3C-8053-227E539006F8Q33832177-7BB69B77-5050-4A56-8494-A4C1891C75D8Q33851772-6547591B-FAF3-4085-8DBD-92C589527E83Q33877578-22001113-7F86-427D-BE6B-40DA126630FEQ33877805-CC557B3F-FF60-4E9B-A0B7-B35D92166ECAQ33883038-08BDA95E-5DC2-4FC8-BFAA-4C79FBE7EB84Q33891405-489D89D6-5769-4795-A8CD-55C687C34728Q34134296-BA66399E-6A88-44C4-885F-D3D852EBE9CDQ34502294-5ECECAE8-E20E-4543-AEBA-4B181B7ECBD9Q34647390-D51A7797-70F1-460C-ACC6-949C60515B75Q34750698-6AD1E8CC-74DA-473A-A031-29D044DEB604Q34774959-15C4A936-F77B-44B6-BB54-AD2B943D0C50Q34827519-C4EEC196-8754-4DB8-9ED6-BA6BD20E8065Q35004571-5125D8BE-346B-4149-8492-34690975BD77Q35585980-62D08F41-B6E3-4B77-B97F-B953947F1F02Q35670773-776E190A-EE5B-4A1F-A5C0-A15FB790E683Q35744922-015620B9-1D9B-4705-97E5-414231C058C3Q35841020-0C7CAB22-466D-49DB-913E-201F10B26C11Q35926253-1C9EB714-47C2-4562-8DFE-356A472374A5Q35976370-B4EF8BFE-42A1-454B-9406-CFE2E7A4782BQ36137908-14B566B7-53E2-447A-92A2-0CB40D85EF98Q36329899-A0E75552-43CA-42E9-B923-06A1D403565E
P2860
Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin resistance, dyslipidemia, atherosclerosis and coronary heart disease
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 10 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Non-alcoholic fatty liver dise ...... sis and coronary heart disease
@en
Non-alcoholic fatty liver dise ...... is and coronary heart disease.
@nl
type
label
Non-alcoholic fatty liver dise ...... sis and coronary heart disease
@en
Non-alcoholic fatty liver dise ...... is and coronary heart disease.
@nl
prefLabel
Non-alcoholic fatty liver dise ...... sis and coronary heart disease
@en
Non-alcoholic fatty liver dise ...... is and coronary heart disease.
@nl
P2860
P50
P921
P356
P1433
P1476
Non-alcoholic fatty liver dise ...... sis and coronary heart disease
@en
P2093
Emma Buzzigoli
Mariangela Morelli
P2860
P304
P356
10.3390/NU5051544
P5008
P577
2013-05-10T00:00:00Z